logo

Follow/Share
  • About
  • Careers
  • Events
  • Contact
  • Diversity
  • Alumni
  • English
    • 普通話

Contacts

Mark H. Gallant

Chair, Health Law
P (215) 665-4136

Lauren A. Tulli

Member
P (215) 665-6907

Lisa Calvo Haas

Chief Marketing Officer
P (215) 665-2792

  • People
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z
    • |
    • View all people



  • Industries
    • Energy & Utilities
    • Food & Beverage
    • Gaming
    • Health Care & Life Sciences
    • Insurance
    • Media, Entertainment & Sports
    • Real Estate & Construction
    • Technology
    • Transportation & Logistics
    • Venture Capital
  • Practice Areas
      • Antitrust & Trade Regulation
      • Bankruptcy, Insolvency & Restructuring
      • China Practice
      • Corporate
      • Emerging Business & Venture Capital
      • Energy, Environmental & Public Utilities
      • Health Care
      • International
      • Mergers & Acquisitions
      • Private Client Services
      • Public & Project Finance
      • Securities
      • Tax
      • Transportation & Logistics
      Business/Corporate
      • Antitrust & Trade Regulation
      • Aviation
      • Consumer Protection & Privacy
      • Cozen O'Connor Public Strategies - Government Relations
      • Energy, Environmental & Public Utilities
      • Health Care
      • Privacy & Data Security
      • Transportation & Logistics
      Government & Regulatory
      • Bad Faith
      • Cyber/Technology
      • Insurance Corporate & Regulatory
      • Insurance Coverage & Claims Litigation
      • Professional Liability Insurance Coverage
      • Reinsurance
      • Subrogation & Recovery
      Insurance
      • Biologics/Biosimilars
      • Domains
      • e-commerce
      • Entertainment Law
      • Franchising
      • Hatch-Waxman Litigation
      • Intellectual Property Litigation
      • Licensing & Transfer
      • Patents
      • Right of Privacy & Right of Publicity
      • Trade Secrets & Unfair Competition
      • Trademark & Copyright
      Intellectual Property
      • Employee Benefits & Executive Compensation
      • Employment Litigation
      • Immigration
      • Labor Relations & Disputes
      • Trade Secrets & Unfair Competition
      Labor & Employment
      • Antitrust Litigation & Investigations
      • Appellate
      • Aviation
      • Bankruptcy, Insolvency & Restructuring
      • Complex Litigation
      • Construction
      • Cyber/Technology
      • Electronic Discovery
      • Energy, Environmental & Public Utilities
      • Family Law
      • Franchise Disputes
      • Health Care
      • Insurance Coverage & Claims Litigation
      • Intellectual Property Litigation
      • Internal Investigations & Criminal Defense
      • Products Liability
      • Professional Liability
      • Real Estate Litigation
      • Securities Litigation & Enforcement
      • Self-insured Recovery
      • Transportation & Logistics Litigation
      Litigation
      • Brownfields Development
      • Distressed Real Estate
      • Eminent Domain
      • Office/Retail/Industrial Leasing & Development
      • Real Estate Finance
      • Real Estate Litigation
      • Zoning, Land Use & Development
      Real Estate
      • Subrogation & Recovery
    • Experience
      • Client Stories
      • Experience
    • Offices
      • Atlanta
      • New York
      • Charlotte
      • Philadelphia
      • Cherry Hill
      • San Diego
      • Chicago
      • Seattle
      • Dallas
      • Toronto
      • Denver
      • Washington, D.C.
      • Harrisburg
      • West Conshohocken
      • Houston
      • West Palm Beach
      • London
      • Wilkes-Barre
      • Los Angeles
      • Wilmington
      • Miami
    • News & Resources
      • Blogs
      • News & Resources
      • Media Resources
      • Publications
    • OVERVIEW
    • PEOPLE
    • EXPERIENCE
    • PUBLICATIONS
    • EVENTS
    • PRESS RELEASES
    • NEWS

    Health Care & Life Sciences

    Cozen O'Connor Blogs

    Health Law Informer

    Health care and life sciences is inarguably one of the largest, most heavily regulated, and fastest-growing industries in the U.S. economy. It is also utterly unique. Health care and life sciences companies do not function simply to maximize returns, and the standard economic forces of supply and demand do not apply. Ultimately, every player in this market—whether a hospital, biotechnology company, nursing home, or medical equipment manufacturer—is responsible for helping people lead longer and healthier lives.

    To be effective, advocates for the health care and life sciences industry must integrate an awareness of and commitment to this underlying responsibility into every element of their work. The members of Cozen O’Connor’s health care and life sciences industry team understand this social mission as well as its legal, political, macroeconomic, and business consequences for our clients. Attorneys at the firm have been providing excellent counsel to health care and life science companies for decades.

    Our client base includes a diverse array of companies. In the health care sector, we serve leading pharmaceutical companies, hospitals, health care systems, medical equipment manufacturers and suppliers, assisted living facilities, academic institutions, insurers, and physician groups. In the life sciences sector, we serve drug developers, biotechnology companies, medical device manufacturers, and cutting-edge startups.

    For health care and life sciences clients, it is essential that their attorneys have deep industry expertise. Good commercial litigators or corporate lawyers can serve a chain of shoe stores just as capably as a chain of pizza parlors, but that does not mean they can serve a chain of hospitals. The health and life sciences field is so heavily regulated that all legal work in this arena must be grounded in a specific and sophisticated understanding of health laws. At Cozen O’Connor, we have litigators, transactional lawyers, and corporate counselors who are both leaders in their legal disciplines and masters of this complex and ever-changing statutory regime.

     

    SERVICE AREAS

    Litigation

    • Handle third-party payor litigation and reimbursement proceedings
    • Represent clients in fraud, abuse, Stark Law, and False Claims Act cases
    • Conduct internal investigations and respond to enforcement acts by federal and state agencies
    • Represent health care and life sciences companies in intellectual property, employment, antitrust, and other commercial litigation

    Transactional

    • Arrange mergers, acquisitions, consolidations, divestitures, workouts, and restructurings
    • Negotiate joint ventures, alliances, and co-management arrangements
    • Resolve antitrust, tax, and bankruptcy issues for health care and life sciences organizations
    • Arrange financings through public offerings, bonds, loans, and other investment vehicles
    • Conduct major real estate deals for industry clients

    Regulatory

    • Advise on privacy, confidentiality, HIPAA compliance, and safety laws
    • Handle Medicare, Medicaid, and other third-party reimbursement matters
    • Develop and assess regulatory compliance programs for health care and life science clients
    • Counsel clients on employee benefits, credentialing, and executive compensation strategies

     

    RELATED PRACTICES

    • Health Law
    • Labor & Employment
    • Employee Benefits & Executive Compensation
    • Antitrust
    • Real Estate
    • Public & Project Finance
    • Intellectual Property
    • Products Liability
    • Cozen O’Connor Public Strategies, LLC

    People

    Mark L. Alderman Member Washington, D.C. (202) 912-4846
    David L. Barron Member Houston (713) 750-3132
    Katie R. Beran Associate Philadelphia (215) 665-2141
    L. Stephen Bowers Member Philadelphia (215) 665-7283
    Simeon D. Brier Member Miami (305) 704-5942
    Robert A. Chu Associate Philadelphia (215) 665-2101
    Linda Kaiser Conley Member Philadelphia (215) 665-2099
    Raymond G. Console Member Cherry Hill (856) 910-5011
    Robert V. Dell´Osa Member Philadelphia (215) 665-2745
    Gregory M. Fliszar Member Philadelphia (215) 665-7276
    Debra Steiner Friedman Member Philadelphia (215) 665-3719
    Mark H. Gallant Chair, Health Law Philadelphia (215) 665-4136
    Jonathan M. Grossman Member Washington, D.C. (202) 912-4866
    Lisa Calvo Haas Chief Marketing Officer Philadelphia (215) 665-2792
    Deborah Alford Hamilton Government Relations Specialist Wilmington (302) 295-2007
    Louis M. Heidelberger Member New York (212) 883.2221
    Katherine M. Layman Member Philadelphia (215) 665-2746
    A. Kenneth Levine Member West Palm Beach (561) 515-5256
    Iden Grant Martyn Member Washington, D.C. (202) 912-4800
    Judy Wang Mayer Associate Philadelphia (215) 665-4737
    Suzanne S. Mayes Chair, Public & Project Finance Philadelphia (215) 665-6922
    Anna M. McDonough Member Philadelphia (215) 665-4780
    Camille M. Miller Co-Chair, Intellectual Property Group Philadelphia (215) 665-7273
    John P. Moses Of Counsel Wilkes-Barre (570) 970-8030
    Jeffrey L. Nash Member Cherry Hill (856) 910-5003
    David S. Nelson Member Philadelphia (215) 665-2000
    Patrick J. O´Connor Vice Chairman West Conshohocken (610) 941-2375
    Elena Park Member West Conshohocken (610) 941-2359
    E. Gerald Riesenbach Member Philadelphia (215) 665-4159
    Colin T. Roskey Member Philadelphia (215) 665-4100
    Richard J. Silpe Member Philadelphia (215) 665-2704
    Adam M. Silverman Member Philadelphia (215) 665-2161
    Lauren A. Tulli Member Philadelphia (215) 665-6907
    Charles H. Wilson Member Houston (713) 750-3117

    Experience

    Represented a client in an administrative proceeding involving the federal government’s Retiree Drug Subsidy Program (RDSP) in which our attorneys persuaded the government to grant the client a rare exception to the filing requirement to redress the inequitable result of routine application of the program rules.


    Prior to trial, represented Sun Pharma as a defendant for infringement, by the FDA filing of a generic drug application, of a patent covering the drug pantoprazole. The preliminary injunction was denied.


    Represented Morphotek, Inc., a biotech company, from his introduction of the principals to the angel investors who invested $2 million to over $40 million of venture capital financings from a group of prominent venture funds, including S.R. One, Limited, Forward Ventures, China Development Industrial Bank, Rock Maple Ventures, Burrill & Co., CB Health Ventures, and Flagship Ventures. Subsequently handled the $350 million acquisition of Morphotek by Japanese health care research and development firm ESAI Corporation.


    Represented a group of actively practicing physicians/minority owners in connection with their interests in the sale of Kremer Laser Eye Centers to a public company, TLC Vision Corporation. Our clients were only selling a portion of their stock, and chose to invest in the successor company.


    Completed a $40 million transaction for our client, Blue Cross of Northeastern Pennsylvania, in the sale of a 40 percent interest in its two operating subsidiaries.


    Completed the $31.5 million acquisition of the Commonwealth Corporate Center, an office park situated on four contiguous properties comprising more than 80 acres in Horsham, PA, from Advanta Corp. for our client, Centocor, Inc., a subsidiary of Johnson & Johnson.


    Represented Mid-Atlantic Health Care, Baltimore MD, in a $75 million acquisition of five Philadelphia nursing homes.


    Represented the Debtor, the owner and manager of a 220-bed nursing home, in its Chapter 11 case in the United States Bankruptcy Court for the District of New Jersey, where we confirmed a Chapter 11 plan restructuring the Client’s secured debt, real-property leases and union obligations, and enabled the Debtor’s equity interests to maintain ownership of the entity, all while maintaining a consistently high level of care for residents.


    Represented New Jersey Hospital Association in New Jersey Hospital Ass'n in v. Waldman, 73 F.3d 509 (3d Cir. 1995). Challenge by New Jersey hospitals under Boren Amendment to reduction of DRG rates and adequacy of disproportionate share payments.


    Represented Mercy Catholic Medical Center in Mercy Catholic Medical Ctr. V. Thompson, 380 F.3d 142 (3d Cir. 2004). Invalidating CMS audit rules used to set average per resident amount; requiring intermediaries to increase costs not previously claimed as GME expense, but verified by subsequent time studies.


    Represented Children's Seashore House in Children's Seashore House v. Waldman, 197 F. 654 (3d Cir. 1999). Ordering New Jersey to pay Medicaid disproportionate share adjustments to out-of-state providers.


    Provided guidance to hospital client regarding inter-relationship of state and federal patient safety laws.


    Assisted a local hospital obtain training reimbursement rates from Medicare after an 8-year fight from the intitial administrative appeal challenging the government's interpretation of its re-audit rules to a federal case in the Third Circuit. The court ordered the government to recalculate its reimbursements without reliance on its discriminatory re-audit rule.


    Prohibited Medicare program from recouping pre-petition overpayments from hospitals that have filed for bankruptcy in In re: Universal Medical Center, 973 F.2d 1065 (3d Cir. 1992).


    Advised a physician organization on compliance with the antitrust laws in connection with negotiating managed care contracts on behalf of its member constituents.


    Assisted ambulatory care facility in developing patient safety program.


    Defended a multi-state provider of behavioral health services against a False Claims Act suit brought by the federal and state governments, and advising the client with respect to its obligations under a resulting Corporate Integrity Agreement.


    Represented the American Hospital Association and Association of American Medical Colleges as friends of the court in In re: Cardiac Device Litigation (Second Circuit U.S. Court of Appeal) involving Medicare billings for services including investigational devices


    Represented physician group practices before the New Jersey Board of Medical Examiners in connection with compliance with the New Jersey anti-referral law, commonly referred to as the "Codey Law."


    Represented the underwriters in structuring bond financing for six assisted living facilities in Pennsylvania, New Jersey and Delaware, including a new $54 million campus for the Philadelphia Geriatric Center through the insurance of unrated tax-exempt bonds.


    Handled the consolidation of two Healthcare systems in Pennsylvania including performing due diligence, negotiating and drafting all required definitive documents, communicating with federal and state regulators and with the Pennsylvania Attorney General's office, and obtaining private letter rulings from the Internal Revenue Service related to the consolidation.


    Represented Diagnostek, Inc., a NYSE mail order pharmacy, which was subsequently acquired by Value Health (now Express Scripts) for $500 million.


    Represented national nursing home chain in Medicare Part A appeals involving "related party" (institutional pharmacy) reimbursements.


    Defended our client, a regional hospital and health care system, when it was sued in federal court for age and national orientation discrimination by a former employee who had been terminated from his employment for theft of time. We won summary judgment on behalf of our client. We prevailed in the Court of Appeals for the Third Circuit after the former employee appealed the summary judgment decision.


    Served as lead trial counsel for Arora Board Review and various doctors in defense of claims of copyright infringement and breach of contract filed by the American Board of Internal Medicine.


    Served as lead trial counsel for Celgene Corporation, a global biotechnology and pharmaceutical company, where we succeeded in obtaining a favorable settlement whereby a pharmaceutical company agreed to phase out all use of the term IMID.


    Represented Sandoz Inc. in King and Mutual v. Sandoz, 08-5974 (D.N.J.), in which Sandoz was alleged to infringe a patent concerning the muscle relaxant Skelaxin®. After an eight-day jury trial, the jury found the patent both invalid and not infringed. Both King and Mutual appealed, but then withdrew their appeal after Sandoz filed its appellate brief.


    In Aventis v. Dr. Reddy’s, three of Dr. Reddy’s generic fexofenadine products were alleged to infringe a total of seven patents, four patents directed to fexofenadine formulations and three patents directed to methods of treatment using fexofenadine. After a bench trial and with several summary judgment motions filed by Dr. Reddy’s pending, the plaintiff capitulated, providing Dr. Reddy’s with a no-strings-attached covenant not to sue with respect to all asserted patents.


    Designed and implemented the litigation strategy as counsel for the second generic challenger in a patent infringement case involving patentee's drug, TAMBACOR©, a heart medication with sales exceeding $150 million. Summary judgment of noninfringement was obtained in less than six months after patentee filed its complaint in the U.S. District Court for the District of Minnesota. This judgment began tolling the 180-day exclusivity period of the first generic challenger, who was still facing trial and not yet on the market. The Federal Circuit subsequently affirmed the decision and, in doing so, expedited the client's market entry by many years. The Federal Circuit's decision resulted in a leading opinion on the proper application of the Hatch-Waxman Act, Minnesota Mining & Manufacturing Co. v. Barr Labs.


    Designed and implemented the litigation strategy as lead counsel for the declaratory-judgment plaintiff, a generic drug maker, in a patent infringement case involving Sanofi-Aventis’ drug RILUTEK©, before the Honorable Judge Farnan in the U.S. District Court for the District of Delaware. A preemptory declaratory judgment attack precluded patentee from relying on the statutory 30-month stay on approval, resulting in approval of the generic alternative only six months after the ANDA was filed. Impax Labs., Inc. v. Aventis Pharmaceuticals, Inc.


    Represented Wockhardt in ANDA litigation regarding LUNESTA®, the active ingredient of which is eszopiclone. Settled prior to trial on terms the client found favorable.


    Represented Portico Systems of Delaware in its acquisition by McKesson Health Solutions, a subsidiary of McKesson Corporation (15th on the FORTUNE 500), for approximately $90 million. We represented this company since its formation and through multiple transactions, including several investments by Safeguard Scientifics and Edison Venture Fund.


    Assisted medical device client in becoming compliant with Physician Payment Sunshine Act.


    Developed compliance programs for hospital based pharmacy and home health provider.


    Served as regulatory counsel for hospice provider.


    Provided counsel to device manufacturer on vendor/marketing issues.


    Represented dental practices in multiple mergers and acquisitions.


    Established ambulatory surgery facilities and assisted in compliance with state and federal regulations, including Stark.


    Represented nursing homes in New Jersey and Florida in asset sale of facilities.


    Represented a major hospital center in an arbitrated dispute with a Medicaid managed care organization (MCO). Over the hospital’s objection, the MCO sought to justify failures to pay for hospital services on medical necessity grounds, even though the MCO had denied the relevant claims solely for lack of authorization. After the arbitrator ruled in the hospital’s favor on this issue and a variety of others, the matter settled on favorable terms for our client.


    Represented an air ambulance company in a dispute with a Medicaid managed care organization (MCO) that refused to pay more for out-of-network transportation services than the federal default rate applicable to emergency hospital services. We brought suit alleging that the default rate did not apply, that the MCO had breached an implied-in-fact contract with the company and the terms under which it participated as a Medicaid plan, and that the MCO had been unjustly enriched. After the court denied most of a motion to dismiss by defendant, the matter settled on favorable terms for our client.


    Represented the purchaser of 5 skilled nursing facilities in Philadelphia, Pennsylvania.


    Represented the seller of a skilled nursing facility in Lakewood, New Jersey.


    Represented the seller of a skilled nursing facility in Trenton, New Jersey.


    Represented the seller of 3 skilled nursing facilities in South Florida.


    Represented a U.S.-based medical device company in acquisition of European-based competitor


    Represented a U.S. life sciences company in a license and distribution transaction with a top 5 worldwide pharmaceutical company.


    Represented a U.K.-based pharmaceutical packaging company in establishing U.S. operations including engagement of distribution team and negotiation of supply agreements with pharmaceutical companies.


    Represented a German-based biotech company in a patent infringement action regarding a method for synthesizing nucleic acids.


    Represented a global pharmaceutical company in the largest global M&A transaction as of 1996.


    Represented a U.S. innovative medical device developer and distributor in acquisition of 100% equity interests of a U.S. competitor.


    Represented seller of a 78% equity position in a physician owned 782 bed full service hospital in Houston, Texas.


    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Medicis' acne product SOLODYN® (minocycline hydrochloride).


    Lead counsel for Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Endo's pain product OPANA® ER (oxymorphone hydrochloride).


    Represented Apotex Inc., in a patent infringement action regarding Apotex's ANDA to make a generic version of Wyeth's anti-depressant product EFFEXOR XR® (venlafaxine hydrochloride). Settled on favorable terms during trial.


    Represented Apotex Inc., in a patent infringement action regarding Apotex's ANDA to make a generic version of Sanofi-Aventis' anticancer product TAXOTERE®, the active ingredient of which is docetaxel. Following a two-week trial, obtained an order for Apotex striking down the patents-in-issue as invalid as obvious and unenforceable due to Sanofi-Aventis' inequitable conduct in procuring the patents. Successfully argued on appeal with the Federal Circuit affirming trial court decision (April 2012). Of import is that inequitable conduct defense remains viable in ANDA litigations because of this ruling.


    Handled a patent infringement action regarding Apotex's ANDA to make a generic version of Pfizer's migraine product Relpax®, the active ingredient of which is eletriptan hydrobromide.


    Represented Sandoz Inc. in a patent infringement action regarding Eon/Sandoz's abbreviated new drug application (ANDA) to make a generic version of Pfizer’s anti-seizure product Neurontin®, the active ingredient of which is gabapentin.


    Handled a patent infringement action regarding Schwarz Pharma’s ANDA to make a generic version of Braintree Labs’ constipation product Miralax®, the active ingredient of which is polyethylene glycol. During discovery, Braintree dismissed its infringement complaint, waiving the remaining portion of the 30 month stay on FDA approval of Schwarz Pharma’s product.


    Represented Sony Corporation of America in its acquisition of iCyt Mission Technology, Inc., a leading producer of high-performance cell sorters used for stem cell and disease research.


    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Alcon's eye allergy product PANTANOL® (olopatadine hydrochloride).


    Represented Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Merck's anti-nausea product EMEND® (aprepitant).


    Represented our client in a patent infringement action regarding Actavis' ANDA to make a generic version of King's pain product AVINZA®, the active ingredient of which is morphine sulfate.


    Represented our client, Mylan Pharmaceuticals, Inc., in a patent infringement action regarding Mylan's ANDA to make a generic version of Pfizer's cardiovascular product CADUET®, the active ingredients of which are atorvastatin calcium and amlodipine besylate. Settled prior to trial.


    Represented Apotex Inc., in a patent infringement action regarding Apotex's ANDA to make a generic version of Procter's osteoporosis product ACTONEL® (risedronate).


    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Abbott’s ZEMPLAR® (paricalcitol).


    Represented Apotex Inc., in a patent infringement action regarding Apotex’s ANDA to make a generic version of LYSTEDA (tranexamic acid). Matter pending.


    Represented Apotex Inc., in a patent infringement action regarding Apotex’s ANDA to make a generic version of ACULAR LS® (0.4% ketorolac tromethamine). Matter pending.


    Represented Apotex Inc., in a patent infringement action regarding Apotex’s ANDA to make a generic version of PRISTIQ® (desvenlafaxine). Matter pending.


    Represented Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Shire’s ADHD product INTUNIV® (guanfacine hydrochloride). Matter pending.


    Represented Sandoz Inc., in a patent infringement action regarding Sandoz’s ANDA to make a generic version of Roche’s VALCYTE® (valganciclovir hydrochloride). Matter pending.


    Represented our client, Sandoz Inc., in patent infringement action regarding Sandoz’s ANDA to make a generic version of Helsinn’s anti-nausea product ALOXI® (palonosetron hydrochloride injection). Matter pending.


    Represented our client in a patent infringement action regarding InnoPharma’s ANDA to make a generic version of Spectrum’s FUSILEV® (levoleucovorin). Matter pending.


    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz’s ANDA to make a generic version of Abbott’s cholesterol medication TRILIPIX® (fenofibric acid). Matter pending.


    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz’s ANDA to make a generic version of Abbott’s cholesterol product NIASPAN® (niacin). Matter pending.


    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Alcon's eye allergy product PATANOL® (olopatadine hydrochloride).


    Lead counsel in damage phase of a patent infringement action regarding Sandoz's ANDA to make a generic version of Pfizer’s seizure and neuropathic pain product, Neurontin®, the active ingredient of which is gabapentin.


    Handled a patent infringement action regarding Sandoz's ANDA to make a generic version of Pfizer’s antifungal medication VFEND®, the active ingredient of which is voriconazole.


    Handled a patent infringement action regarding Sandoz's ANDA to make a generic version of Pfizer’s antimuscarinic tablet Detrol and Detrol LA®, the active ingredient of which is tolterodine tartrate.


    Handled a patent infringement action regarding Sandoz's ANDA to make a generic version of Alcon's eye allergy product Pataday®, the active ingredient of which is olopatadine hydrochloride.


    Represented our client in a patent infringement action regarding Apotex’s ANDA to make a generic version of AVODART® (dutasteride). Matter pending.


    Publications


    CMS Proposes FY 2014 Prospective Payment System Update Rules for Skilled Nursing Facilities

    May 09, 2013

    Cozen O’Connor believes the updated rate represents a fair starting point and that the Proposed Rule offers stakeholders an important opportunity to provide comments that CMS specifically suggests could help shape final policy. MORE


    An Overview of the IRS’s Proposed Rule on Community Health Needs Assessments

    May 07, 2013

    The Internal Revenue Service issued proposed regulations addressing the requirement under Section 501(r)(3) of the Internal Revenue Code that tax-exempt hospitals conduct community health needs assessments. The proposed regulations also provide details on related reporting obligations and the consequences of noncompliance with CHNA. MORE


    An Overview of Proposed Rule on Community Health Needs Assessments [Health Lawyers Weekly]

    May 03, 2013

    Judy Mayer, an associate in the firm's Health Law Practice Group in Philadelphia published an article titled, MORE


    Congress Drafts Legislation that would Expand the FDA’s Role in Regulating Compounding Pharmacies [Health Law Informer]

    May 02, 2013

    On April 26, Tom Harkin (D-IA), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, unveiled bipartisan draft legislation (Draft Legislation) to clarify federal oversight of pharmaceutical compounding. MORE


    CMS Proposes Prospective Payment System Update Rules for Inpatient and Long Term Care Hospitals

    May 01, 2013

    On April 26, CMS issued a crucial payment system rule that proposes updated rates and regulatory policies for inpatient and for long term care hospitals. The Proposed Rule incorporates update factors for FY 2014 rates effective October 1, 2013 and sets forth new proposed policies and policy revisions. MORE


    IP: Obamacare’s Constitutional Impact on Patents [InsideCounsel]

    April 30, 2013

    A variety of patent issues arise from the act’s Biologics Price Competition and Innovation Act. MORE


    Hospitals Prevail in Effort to Include Pennsylvania GA Days in the Medicare DSH Calculation [Health Law Alert]

    April 23, 2013

    Two of Mercy Health System’s hospitals (Nazareth Hospital and the former St. Agnes Medical Center) successfully challenged, before Judge Ludwig of the U.S. District Court for the Eastern District of Pennsylvania, the Secretary of Health and Human Services’ exclusion of days of care provided to Pennsylvania’s General Assistance (GA) patients in fiscal year 2002 from the formula used to determine the hospitals’ Medicare disproportionate share hospital (DSH) payments (Nazareth Hosp. v. Sebelius, E.D. Pa. No. 2:10-cv-03513-EL, April 8, 2013). The exclusion resulted in lower Medicare DSH payments. MORE


    Highlights of the Omnibus HIPAA/HITECH Final Rule [Cozen O'Connor Whitepaper]

    March 07, 2013

    On January 25, 2013, the Office of Civil Rights (OCR) of the Department of Health & Human Services (HHS) published the long-awaited omnibus final regulation governing health data privacy, security and enforcement (Omnibus Rule). The Omnibus Rule is a group of regulations that finalizes four sets of proposed or interim final rules, including changes to the Health Insurance Portability and Accountability Act (HIPAA) Privacy and Security Rules mandated by the Health Information Technology for Economic and Clinical Health (HITECH) Act and proposed in 2010; changes to the interim final breach notification rule; modifications to the interim final enforcement rule; and implementation of changes to the Genetic Information Nondiscrimination Act of 2008 (GINA). The Omnibus Rule goes into effect on March 26, 2013, and compliance is required by September 23, 2013. As expected, the Omnibus Rule did not finalize the May 31, 2011 proposed regulation regarding accounting for disclosures. MORE


    Implementing the Affordable Care Act: Countdown to 2014 (The 90-Day Waiting Period Limitation) [ACA Alert]

    February 12, 2013

    Section 2708 of the Affordable Care Act (ACA) provides that group health insurers and group health plans may not impose a waiting period on participants if the waiting period is more than 90 days. The Internal Revenue Service, the Department of Labor, and the Department of Health and Human Services have issued temporary guidance to assist both grandfathered and non-grandfathered plans in complying with this standard. Because the guidance issued by the three agencies is substantially identical, this article references only the IRS guidance, published as IRS Notice 2012-59. MORE


    Implementing the Affordable Care Act: Countdown to 2014 (Tax Implications) [ACA Alert]

    January 28, 2013

    Under the Affordable Care Act, a number of significant tax increases go into effect in 2013 and other tax provisions will be implemented during the next several years. MORE


    Implementing the Affordable Care Act: Countdown to 2014 (Introduction) [ACA Alert]

    January 25, 2013

    The countdown to the 2014 implementation of the Affordable Care Act (ACA) has begun. Each week, administrative decisions, guidance, rules and regulations are coming from the federal and state governments to make ACA a functioning health care system for the 21st century. MORE


    HHS Releases the Long-Awaited Final Omnibus HIPAA Rules [Health Law Alert]

    January 22, 2013

    A pre-publication version of the much anticipated final Omnibus Health Insurance Portability and Accountability Act (HIPAA) rule (the Final Rule) was issued January 17, 2013 with publication in the Federal Register scheduled for January 25, 2013. While the Final Rule becomes effective March 26, 2013, covered entities and business associates have until September 23, 2013, to comply and, in the case of existing business associate agreements, covered entities have until September 2014 to make changes. The full breadth of the nearly 600-page rule will take some time to fully analyze. MORE


    The SMART Act: A Bipartisan Attempt to Make the MSP Act Workable [Health Law Alert]

    January 17, 2013

    On January 10, 2013, President Obama signed into law H.R. 1845, which includes the Strengthening Medicare and Repaying Taxpayers Act of 2011 (SMART Act). The SMART Act amends several portions of the Medicare Secondary Payer (MSP) Act that apply to non-group health plans, including liability insurance (including self-insurance), no-fault insurance and workers' compensation plans (together, NGHPs). Although the SMART Act makes significant substantive and procedural amendments to the MSP Act, many practical issues will continue to bedevil parties trying to settle a personal injury claim. MORE


    Taking Aim in 2013: The Government Points Two Barrels at Preventing and Punishing Healthcare Fraud and Abuse [Health Law Informer]

    November 16, 2012

    A few weeks ago we posted on this Blog an article highlighting the “gathering storm” surrounding HIPAA enforcement and predicted an ominous future for hospitals and other providers who fail to develop and maintain adequate HIPAA compliance policies. While there is no doubt the future is bleak for those unwilling to abide by HIPAA’s mandate, the forecast for providers who commit healthcare fraud is equally devastating. MORE


    HIPAA Enforcement - The Gathering Storm Has Arrived [Health Law Alert]

    November 16, 2012

    Since the Health Insurance Portability and Accountability Act (HIPAA) privacy rules became effective in April 2003, there has been minimal enforcement activity by the U.S. Department of Health and Human Services (HHS) Office of Civil Rights (OCR). However, this has changed dramatically over the last two years, as evidenced by some recent high-profile and high penalty enforcement actions taken by OCR. In addition to being concerned about OCR investigations, covered entities and business associates must also be on the alert for enforcement actions by state attorney generals, potential class action lawsuits, and OCR’s HIPAA audit program. MORE


    Seventh Circuit Rules that Medical Necessity Trumps State-Imposed Cap on "Optional" Medicaid Coverage [Health Law Alert]

    October 24, 2012

    Seventh Circuit Rules that Medical Necessity Trumps State-Imposed Cap on "Optional" Medicaid Coverage - Health Law Alert - In a class action lawsuit, the U.S. Court of Appeals for the 7th Circuit recently affirmed a lower court decision granting a preliminary injunction that prevented the state of Indiana from enforcing a $1,000 annual cap on Medicaid coverage for medically necessary dental services, and concluded the cap most likely violated rights granted to Medicaid beneficiaries under federal law. Bontrager v. Indiana Family and Social Services Administration, 2012 U.S. App. LEXIS 20157 (September 26, 2012). MORE


    Pharmaceutical Manufacturers and Consumers, and Congressional Democrats and Republicans AGREE to Increase, Expand and Extend the FDA User Fee Program [Health Law Informer]

    August 15, 2012

    President Obama recently signed a bipartisan bill that authorizes Food and Drug Administration (“FDA” or “Agency”) user fees for five more years and establishes new user fees for the FDA’s review of generic drugs and biosimilar products. MORE


    Third Circuit Rules that Medicare Advantage Plans have a Private Right of Action Under the Medicare Secondary Payer Act [Health Law Alert]

    July 11, 2012

    Third Circuit Rules that Medicare Advantage Plans have a Private Right of Action Under the Medicare Secondary Payer Act - Health Law Alert - On June 28, 2012, the U. S. Court of Appeals for the 3rd Circuit held that the Medicare Secondary Payer Act (the MSP Act) provides Medicare Advantage (MA) plans the same right as the federal government to bring recovery actions against primary payers (i.e., liability insurers, no-fault insurers, self-insured entities). MORE


    Supreme Court Rules on Affordable Health Care Act: Upholds Individual Mandate and Limits Scope of Medicaid Expansion [Health Law Alert]

    June 28, 2012

    Supreme Court Rules on Affordable Health Care Act: Upholds Individual Mandate and Limits Scope of Medicaid Expansion - Health Law Alert - In a heavily anticipated landmark ruling, the Supreme Court has upheld the constitutionality of the so-called “individual mandate” of the Affordable Care Act – i.e., the requirement that those not insured privately, through their employer or through a governmental program, must either purchase minimum essential health insurance coverage or pay a “penalty” for failing to do so. MORE


    Federal Court Sends Mixed Message on Hospital's Right to Payment for Out-of-Network Services [Health Law Alert]

    June 26, 2012

    Federal Court Sends Mixed Message on Hospital's Right to Payment for Out-of-Network Services - Health Law Alert - Hospitals seeking reimbursement from a Medicaid managed care organization (MCO) for non-contracted services, and without the benefit of a single case agreement, need a legal basis to compel payment by the MCO. MORE


    Trojan Horse or Meaningful Medicaid Reform? [Health Law Informer]

    June 22, 2012

    The Centers for Medicare and Medicaid Services (CMS) has outlined its plan to temporarily raise Medicaid rates to Medicare levels for primary care services, and pay states to cover the difference. On May 11, 2012, CMS issued a proposed rule requiring Medicaid payment for primary care services furnished by eligible physicians at rates “not less than the Medicare rates” for fiscal years 2013 and 2014. MORE


    CMS Issues Proposed Guidelines for Protecting Medicare's Interests When a Settlement Involves Future Medical Care [Health Law Alert]

    June 22, 2012

    CMS Issues Proposed Guidelines for Protecting Medicare's Interests When a Settlement Involves Future Medical Care - Health Law Alert - Until now, guidance as to how parties should address future medical care in liability settlements has been virtually non-existent. MORE


    WARNING: HHS Now Combating HIPAA Violations with HITECH Weaponry [Health Law Alert!]

    March 23, 2012

    WARNING: HHS Now Combating HIPAA Violations with HITECH Weaponry - Health Law Alert! - On March 13, 2012-almost 30 months after becoming one of the first entities to self-report a breach under the Health Information Technology for Economic and Clinical Health (HITECH) Act - BlueCross BlueShield of Tennessee (BCBST) agreed to pay the Department of Health and Human Services (HHS) a record setting $1.5 million civil monetary penalty (CMP) for failing to safeguard protected health information (PHI). MORE


    CMS Issues Proposed Rule on Reporting and Returning Medicare Overpayments [Health Law Alert!]

    February 21, 2012

    CMS Issues Proposed Rule on Reporting and Returning Medicare Overpayments - Health Law Alert! - On February 16, 2012, the Centers for Medicare & Medicaid Services (CMS) issued a widely anticipated proposed rule (the proposed rule) implementing the statutory requirement of Section 6402(a) of the Affordable Care Act (the ACA) that providers and
    suppliers report and return overpayments from Medicare and Medicaid. MORE


    On First Anniversary, a Look at Challenges to Health Care [The Legal Intelligencer]

    March 23, 2011

    On First Anniversary, a Look at Challenges to Health Care - The Legal Intelligencer - On its one-year anniversary, the sweeping health care reform law — referred to as the "Affordable Care Act" (ACA) if you like it, and "Obamacare" if you don't — is embroiled in litigation. Its fate, like that of the 2000 presidential election, is likely to be determined by the Supreme Court. MORE


    Adverse Incident Reports: How Many Is Too Many? [Life Sciences Alert]

    January 18, 2011

    Adverse Incident Reports: How Many Is Too Many? - Life Sciences Alert - On January 10, 2011, the U.S. Supreme Court heard argument in the matter Siracusano v. Matrixx Initiatives, Inc., 585 F.3d 1167 (9th Cir. 2009), and suggested that some major changes may be in store for pharmaceutical companies which could forever alter how they handle adverse reports. MORE


    CMS Voluntary Self-Referral Disclosure Protocol: The Good, The Bad, and The Ugly [Health Law Alert!]

    November 17, 2010

    CMS Voluntary Self-Referral Disclosure Protocol: The Good, The Bad, and The Ugly - Health Law Alert! - On September 23, the Centers for Medicare & Medicaid Services (CMS) released the much anticipated Medicare self-referral disclosure protocol (SRDP). CMS was required to establish the SRDP by Section 6409 of the Affordable Care Act (ACA), which obligated the Secretary of Health and Human Services to inform providers and suppliers how to self-disclose actual or potential violations of the Stark law. MORE


    CMS Delays Section 111 Reporting for Liability Insurers [Health Law Alert!]

    November 16, 2010

    CMS Delays Section 111 Reporting for Liability Insurers - Health Law Alert! - the Centers for Medicare & Medicaid Services (CMS) announced a one-year delay in the implementation of certain reporting obligations under Section 111 of the Medicare, Medicaid, and SCHIP Extension Act of 2007 for claims involving liability insurers (including self-insured entities). Claims involving workers’ compensation and no-fault insurance, however, must be reported as scheduled in the first calendar quarter of 2011. The net result is a two-tiered implementation timeline. MORE


    The Difficulty in Certifying a Class Action Against Drug Companies [Life Sciences Alert!]

    November 01, 2010

    The Difficulty in Certifying a Class Action Against Drug Companies - Life Sciences Alert! - Three cases decided over the past few months demonstrate the difficulty with certifying class actions by third-party payors (TPPs) against drug companies. MORE


    Investigational Devices and the Defenses that Protect Them [Cozen O'Connor Paper]

    October 22, 2010

    Investigational Devices and the Defenses that Protect Them - Cozen O'Connor Paper - MORE


    Cozen O'Connor Webinar [Smoothing the Wrinkles of Off-Label Promotion: Allergan's Preemptive Strike Against the FDA]

    September 09, 2010

    Cozen O'Connor Webinar - Smoothing the Wrinkles of Off-Label Promotion: Allergan's Preemptive Strike Against the FDA - MORE


    Proposed New Rules Implementing HITECH Amendments to HIPAA Make Significant Changes [Health Law Alert!]

    August 03, 2010

    Proposed New Rules Implementing HITECH Amendments to HIPAA Make Significant Changes - Health Law Alert! - On July 14, 2010, the Department of Health and Human Services (“HHS”) issued a Notice of Proposed Rulemaking (the “Proposed Regulations”) to modify certain regulations that implement the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”). Specifically, the Proposed Regulations implement statutory amendments to HIPAA’s Privacy, Security, and Enforcement Rules made by the Health Information Technology for Economic and Clinical Health Act (“HITECH”), MORE


    Stark Realities of Health Care Reform [Health Law Alert!]

    May 12, 2010

    Stark Realities of Health Care Reform - Health Law Alert! - Our Health Law Alert of April 26, 2010 summarized recent amendments to the Anti-Kickback Statute (“AKS”) concerning “reverse” federal false claims act (“FCA”) and the implications of the requirement of Section 6402 of the Patient Protection and Affordable Care Act of 2010, Pub. L. No. 111-148 (the “PPACA”) to report and refund “overpayments” by Medicare and Medicaid within sixty (60) days of “identification.” An “overpayment” is defined to MORE


    Health Care Reform Imposes New Compliance Requirements on Tax-Exempt Hospitals [Health Law Alert!]

    May 10, 2010

    Health Care Reform Imposes New Compliance Requirements on Tax-Exempt Hospitals - Health Law Alert! - The Patient Protection and Affordable Care Act, signed into law on March 23, 2010, P.L. 111-148 (the "Act"), contains specific requirements for hospitals that wish to receive or maintain their tax-exempt status under section 501(c)(3) of the Internal Revenue Code of 1986, as amended (the "Code"). In particular, Section 9007 of the Act adds new sectiion 501(r) to the Code, which supplements the community benefit standard generally applicable to tax-exempt hospitals. MORE


    Providers Beware: Health Care Reforms Make Failing to Promptly Refund Overpayments—Including Those Attributable to Identified Stark Violations—Potential False Claims Act Violations [Health Law Alert!]

    April 26, 2010

    Providers Beware: Health Care Reforms Make Failing to Promptly Refund Overpayments—Including Those Attributable to Identified Stark Violations—Potential False Claims Act Violations - Health Law Alert! - By linking the retention of program overpayments and potential liability under the False Claims Act (FCA), the Patient Protection and Affordable Care Act of 2010 (PPACA) has dramatically expanded the scope of exposure for health care providers under the FCA. Potential overpayments to providers—including but not limited to such things as garden variety duplicate payments to discoveries of Medicare payments for designated health services (DHS) provided on referrals from MORE


    Medicare Secondary Payer Update - CMS Delays Reporting Deadlines [Health Law Alert!]

    April 19, 2010

    Medicare Secondary Payer Update - CMS Delays Reporting Deadlines - Health Law Alert! - In December 2007, Congress amended the Medicare Secondary Payer law (MSP) through Section 111 of the Medicare, Medicaid and SCHIP Extension Act (MMSEA). The amendment imposes mandatory reporting obligations on Responsible Reporting Entities (RREs), including liability, self-insured, no-fault and workers’ compensation insurers (collectively referred to as “non-Group Health Plans” or “Non-GHPs”) regarding settlements with Medicare beneficiaries. MORE


    Highmark, Inc. Challenges PA. Insurance Department Investigation [Health Law Alert!]

    March 23, 2010

    Highmark, Inc. Challenges PA. Insurance Department Investigation - Health Law Alert! - Highmark, Inc. has filed a lawsuit in the Commonwealth Court of Pennsylvania challenging the legality of an ongoing Pennsylvania Insurance Department investigation involving potential anticompetitive conduct and/or unfair trade practices by Pennsylvania’s Blue Cross and Blue Shield companies. MORE


    HHS Expands National Practitioner Data Bank Reporting and Access [Health Law Alert!]

    March 02, 2010

    HHS Expands National Practitioner Data Bank Reporting and Access - Health Law Alert! - Effective March 1, 2010, the information collected and available through the National Practitioner Data Bank (NPDB) will expand dramatically to include data obtained pursuant to Section 1921 of the Social Security Act. See 75 Fed. Reg. 4656 (January 28, 2010) (final rule promulgated by the U.S. Department of Health and Human Services (HHS)). Section 1921 requires states to report adverse licensure actions
    against health care practitioners and health care MORE


    Under New Rules, Plans Offering Mental Health and Substance Use Disorder Benefits Must Ensure Parity in Member Costs and Access to Care [Health Law Alert!]

    February 09, 2010

    Under New Rules, Plans Offering Mental Health and Substance Use Disorder Benefits Must Ensure Parity in Member Costs and Access to Care - Health Law Alert! - On February 2, 2010, the Centers for Medicare &
    Medicaid Services, the Internal Revenue Service,
    and the Department of Labor’s Employee Benefits
    Security Administration published long-awaited regulations implementing the Mental Health Parity and Addiction Equity Act of 2008 (the “MHPAEA”).1 The MHPAEA followed the Mental Health Parity Act of 1996, which had previously mandated parity in aggregate lifetime and annual dollar limits between mental health benefits and medical/surgical benefits. MORE


    A New Era in HIPAA Enforcement: Connecticut Attorney General Files First HITECH Act Suit [Health Law Alert!]

    January 18, 2010

    A New Era in HIPAA Enforcement: Connecticut Attorney General Files First HITECH Act Suit - Health Law Alert! - Connecticut Attorney General Richard Blumenthal has filed a lawsuit against Health Net of Connecticut, Inc. for violations of the Health Insurance Portability and Accountability Act (“HIPAA”) following Health Net’s loss of protected health information (“PHI”) and other personally identifiable information.
    MORE


    HIPAA Breach Notification Rule Contains Some Good News [Health Law Alert!]

    August 27, 2009

    HIPAA Breach Notification Rule Contains Some Good News - Health Law Alert! - On August 19, 2009, the U.S. Department of Health
    and Human Services (“HHS”) released an interim
    final rule implementing the breach notification
    provisions of the Health Information Technology for Economic and Clinical Health (“HITECH”) Act, which was passed as part of the American Recovery and Reinvestment Act of 2009. While the new regulation takes effect September 23, 2009, HHS will not impose sanctions for failure to provide notifications for breaches discovered before February 22, 2010. MORE


    FTC Again Delays Enforcement of Red Flags Rule [Health Law Alert!]

    August 07, 2009

    FTC Again Delays Enforcement of Red Flags Rule - Health Law Alert! - On July 29, 2009, just three days before the effective date of the "Red Flags Rule" (the "Rule"), the Federal Trade Commission ("FTC") announced that it would again delay enforcement of Rule from August 1, 2009 until November 1, 2009. The FTC delayed enforcement to allow it to further educate small business and health care providers about the Rule and what they need to do to comply with its requirements MORE


    New Jersey Enforces Limits on Overpayment Recoveries [Health Law Alert!]

    July 09, 2009

    New Jersey Enforces Limits on Overpayment Recoveries - Health Law Alert! - The New Jersey Commissioner of Banking and Insurance
    issues Enforcement Notice requiring Insurer to cease and
    desist from attempting to recoup overpayments based on
    improper extrapolations and to reimburse providers for
    amounts improperly obtained. MORE


    Recent Pennsylvania Decision Requires Disclosure of Medicaid Managed Care Rates [Health Law Alert!]

    July 07, 2009

    Recent Pennsylvania Decision Requires Disclosure of Medicaid Managed Care Rates - Health Law Alert! - Commonwealth Court holds that provider agreements with
    Medicaid managed care plans, including the negotiated
    payment rates contained in those agreements, are subject to
    disclosure under the Pennsylvania Right to Know Law. MORE


    Red Flags Rule Enforcement Delayed...Again [Health Law Alert!]

    May 08, 2009

    Red Flags Rule Enforcement Delayed...Again - Health Law Alert! - On April 30, 2009, the eve of the effective date of the “Red Flags Rule,” the Federal Trade Commission (FTC) announced that it would again delay enforcement of the Rule until August 1, 2009 in order to allow organizations more time to develop and implement written identity theft
    prevention programs. The FTC also announced plans to release a template to help entities that have a low risk of identity theft, such as businesses that know their customers personally, comply with the law MORE


    New Medicare Secondary Payer Requirement: Mandatory Reporting for Liability, No-Fault and Workers Compensation Insurers [Health Law Alert!]

    April 28, 2009

    New Medicare Secondary Payer Requirement: Mandatory Reporting for Liability, No-Fault and Workers Compensation Insurers - Health Law Alert! - The Medicare Secondary Payer law (“MSP”) is again “in the news” for liability (including self-insured), no-fault, and workers compensation insurers. In December 2007, Congress amended the MSP law through Section 111 of the Medicare, Medicaid, and SCHIP Extension Act to impose mandatory reporting requirements on liability, no-fault, and workers’ compensation insurers (collectively referred to as “non-Group
    Health Plans” or “Non-GHPs”) MORE


    The American Recovery and Reinvestment Act of 2009: New Markets Tax Credits Increased by $3 Billion [Health Law Alert!]

    March 20, 2009

    The American Recovery and Reinvestment Act of 2009: New Markets Tax Credits Increased by $3 Billion - Health Law Alert! - The American Recovery and Reinvestment Act of 2009
    increased the tax credits available under the New
    Market Tax Credit program (the “Program”) by $3
    billion. The Program provides tax credits to investors or lenders who provide funding to businesses that are primarily located in, derive their income from, and perform services within a low-income community.1 The tax credits allow an
    investor or lender to get a 39% tax credit over the first 7 years of the investment, MORE


    The American Recovery and Reinvestment Act of 2009: Sweeping Changes to HIPAA Put Business Associates in the Spotlight [Health Law Alert!]

    March 03, 2009

    The American Recovery and Reinvestment Act of 2009: Sweeping Changes to HIPAA Put Business Associates in the Spotlight - Health Law Alert! - On February 17, 2009, President Obama signed into law the Health Information Technology for Economic and Clinical Health Act (“HITECH” or the “Act”), as part of the American Recovery and Reinvestment Act of 2009. The Act made
    sweeping changes to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and the Privacy and Security Rules promulgated under HIPAA. This Alert focuses
    primarily on Subtitle D of HITECH, which includes important MORE


    New Codey Legislation to Provide Certainty After a Year of Limbo [Health Law Alert!]

    February 27, 2009

    New Codey Legislation to Provide Certainty After a Year of Limbo - Health Law Alert! - On February 5, 2009, the New Jersey legislature
    adopted Assembly Bill No. A1933 (the “Bill”), which
    amends the New Jersey Health Care Practitioner
    Self-Referral Law (commonly referred to as the “Codey Law”).
    The Senate adopted an identical bill (S. 787) on December 15,
    2008. The Bill currently awaits Governor Corzine’s signature. MORE


    Protecting Hospital Managed Care Rates as Trade Secrets [Health Lawyers News]

    November 01, 2008

    Protecting Hospital Managed Care Rates as Trade Secrets - Health Lawyers News - As hospital margins tighten and percentages of total revenues from managed care plans grow, hospitals are under increasing pressure to
    negotiate the best possible rates with these plans. Hospitals that can maintain the confi dentiality of their already agreed-upon managed care rates can better maximize their leverage in these high-stakes negotiations with other payors. To this end, the hospital services agreement itself often includes a confi MORE


    FTC Delays Enforcement of Red Flags Rule [Health Law Alert!]

    October 27, 2008

    FTC Delays Enforcement of Red Flags Rule - Health Law Alert! - MORE


    HHS' First Resolution Agreement for Alleged HIPAA Violations and What it Means for You [Health Law Alert!]

    October 01, 2008

    HHS' First Resolution Agreement for Alleged HIPAA Violations and What it Means for You - Health Law Alert! - The Department of Health and Human Services
    (“HHS”) has entered into its first resolution
    agreement with a covered entity to settle alleged
    violations of the Health Insurance Portability and Accountability Act’s (“HIPAA”) privacy and security rules.1 According to HHS, the resolution agreement with Providence Health & Services (“Providence”), a Seattle-based not-for-profit health system, addresses a series MORE


    Supreme Court Weighs in on Scope of False Claims Act [Health Law Alert!]

    June 23, 2008

    Supreme Court Weighs in on Scope of False Claims Act - Health Law Alert! - A recent, unanimous decision of the U.S. Supreme Court appears significantly to reduce the
    potential liability under the False Claims Act for claims health care providers file with private Medicare and Medicaid managed care organizations, as opposed to with the Medicare and Medicaid fee-for-service programs. Allison Engine Co. v. United States ex rel. Sanders, 553 U.S.___ (No. 07-214, June 9, 2008). MORE


    Update: Pennsylvania Hospitals to Pay For Medical Mistakes – Quality of Care At The Forefront [Health Law Alert!]

    February 04, 2008

    Update: Pennsylvania Hospitals to Pay For Medical Mistakes – Quality of Care At The Forefront - Health Law Alert! - Prevention of medical mistakes is a cause celebre, and states are beginning to jump
    on the so-called “never event” bandwagon. Taking a highly proactive stance,
    Governor Edward G. Rendell recently announced that Pennsylvania acute-care
    general hospitals will not be reimbursed by the state Medicaid program for services
    resulting from medical errors. On January 14, 2008, Pennsylvania became just the MORE


    Pending Changes to the Stark Law Phase III [Health Law Alert]

    September 25, 2007

    Pending Changes to the Stark Law Phase III - Health Law Alert - On September 5, 2007, the Centers for Medicare & Medicaid Services (CMS)
    published its long-awaited Phase III regulations regarding the federal ban on
    physician self-referrals, more commonly known as “Stark.” CMS claims that the
    Phase III Stark regulations, effective on December 4, 2007, will reduce the
    regulatory burden on the health care industry, “simplify” the rules and provide MORE


    SURVEY AND ENFORCEMENT IN LONG TERM CARE [Leadership Health Care Spring 2007 Conference]

    March 20, 2007

    SURVEY AND ENFORCEMENT IN LONG TERM CARE - Leadership Health Care Spring 2007 Conference - MORE


    Medicare & Medicaid Issues [Leadership Health Care Spring 2007 Conference]

    March 20, 2007

    Medicare & Medicaid Issues - Leadership Health Care Spring 2007 Conference - MORE


    Litigation [Leadership Health Care Spring 2007 Conference]

    March 20, 2007

    Litigation - Leadership Health Care Spring 2007 Conference - MORE


    HIPAA – Current Issues & Implications for Nursing Homes [Leadership Health Care Spring 2007 Conference]

    March 20, 2007

    HIPAA – Current Issues & Implications for Nursing Homes - Leadership Health Care Spring 2007 Conference - MORE


    Compliance Issues – Fraud and Fraud and Abuse [Leadership Health Care Spring 2007 Conference]

    March 20, 2007

    Compliance Issues – Fraud and Fraud and Abuse - Leadership Health Care Spring 2007 Conference - MORE


    Internet Prescribing: It’s Fast and Easy, But Is It Legal? [ANDREWS LITIGATION REPORTER]

    January 01, 2007

    Internet Prescribing: It’s Fast and Easy, But Is It Legal? - ANDREWS LITIGATION REPORTER - The Internet pharmacy industry is booming and apparently will only get bigger, unless, that is, the federal government decides that prescriptions written without a face-to-face meeting between the physician and patient are invalid. Given its recent enforcement efforts, the government may well be headed in that direction. MORE


    Using Mental Health Records for Research [Compliance Today]

    September 01, 2006

    Using Mental Health Records for Research - Compliance Today - The Health Insurance Portability and Accountability Act’s Privacy Rule (the “Privacy Rule”) strikes a balance between restricting the unauthorized disclosure of medical records and permitting health care providers to operate effectively, including participation in research studies. Specifically, the Privacy Rule takes into account that getting patient authorization for a disclosure can be problematic for researchers who do not interact directly with MORE


    The Deficit Reduction Act of 2005 Imposes New Obligations On Medicaid Providers By January 1, 2007 [Health Law E-lert!]

    August 08, 2006

    The Deficit Reduction Act of 2005 Imposes New Obligations On Medicaid Providers By January 1, 2007 - Health Law E-lert! - MORE


    HIGHLIGHTS OF THE DEFICIT REDUCTION ACT OF 2005 [Health Law E-lert!]

    February 23, 2006

    HIGHLIGHTS OF THE DEFICIT REDUCTION ACT OF 2005 - Health Law E-lert! - MORE

    Events & Seminars

    Managed Care Disputes & Litigation Philadelphia, PA 05/09/2013
    Cybersecurity: Protecting Sensitive Information New York, NY 05/08/2013
    8th Annual Corporate Intellectual Property Law Conference Chicago, IL 02/13/2013
    Implementing The Affordable Care Act - Countdown to 2014 Philadelphia, PA 02/06/2013
    Obama Administration 2.0: What It Means for Employers Houston, TX 01/24/2013
    Supreme Court Health Care Ruling: What It Means for Employers Houston, TX 08/15/2012
    Fundamentals of Health Law Philadelphia, PA 11/15/2011
    Life Sciences Business Development & Acquisitions in Emerging Markets New York, NY 09/26/2011
    Philly I-Day: Philly All Industry Day Philadephia, PA 04/08/2011
    Institute on Medicare and Medicaid Payment Issues Baltimore, MD 03/30/2011
    17th Annual Health Law Institute Philadelphia, PA 03/15/2011
    Medical Records Law Philadelphia, PA 03/01/2011
    Understanding the Changes to HIPAA & HITECH Webinar Webinar 02/25/2011
    Health Law Forum: 2010 Year in Review Philadelphia, PA 02/08/2011
    Examining Health Care Reform Philadelphia, PA 10/26/2010
    Cozen O’Connor’s Life Sciences Leadership Conference: The legal life cycle of a medical device or pharmaceutical product Philadelphia, PA 10/26/2010
    The Patient Protection and Affordable Care Act and the Stark Law: New Rules, New Challenges Webinar via Internet 10/14/2010
    Medicare Part A Reimbursement: the PRRB and Beyond Philadelphia, PA 09/21/2010
    The Patient Protection and Affordable Care Act of 2010: Key Fraud and Abuse, Compliance and Program Integrity Implications for Hospitals Webinar 09/16/2010

    Press Releases


    Cozen O’Connor Adds Health Care Lawyer and Strategist to Philadelphia, Washington, D.C. Offices

    February 04, 2013

    Colin Roskey has joined the Philadelphia and Washington, DC offices as a member of the firm’s Health Care Group and Cozen O’Connor Public Strategies. MORE

    In The News


    Cozen O’Connor Health Law Team Prevails in "Nazareth Hosp. v. Sebelius"

    April 25, 2013

    Mark Gallant, chair of the firm’s Health Law group, and Greg Fliszar secured a victory on behalf of the Mercy Health System against the U.S. Department of Health and Human Services. MORE


    Cozen O’Connor Life Sciences Team Secures Summary Judgment for Global Medical Device Manufacturer

    April 17, 2013

    Lauren Tulli, Jill Caughie and MaryTeresa Soltis secured a summary judgment from the District Court of the Western District of Kentucky in a factually complicated and contentious pain pump case that has been in active litigation for over four years. MORE


    Mark Gallant Quoted in Of Counsel Management Report

    February 01, 2013

    Mark Gallant, a member of the firm, and chair of the Health Law practice group, was quoted in Of Counsel: The Legal Practice and Management Report, in an article titled, “Affordable Care Act, Changing Demographic, Consolidation All Fueling Health Care Law.” MORE


    Mark Gallant and Iden Martyn featured in Bloomberg BNA's Health Care Daily Report

    March 29, 2012

    Mark Gallant and Iden Martyn featured in Bloomberg BNA's Health Care Daily Report MORE

    View other Industry Sectors

    • Energy & Utilities

    • Food & Beverage

    • Gaming

    • Health Care & Life Sciences

    • Insurance

    • Media, Entertainment & Sports

    • Real Estate & Construction

    • Technology

    • Transportation & Logistics

    • Venture Capital


    Related Practices

    • Health Care

    • Corporate

    • Litigation

    • Intellectual Property

    • Labor & Employment

    • Public & Project Finance

    • Tax

    • Cozen O'Connor Public Strategies - Government Relations

    • Privacy & Data Security

    • Sitemap
    • Advanced Search
    • Disclaimer
    • Privacy Policy
    • Attorney Advertising